Expired Study
This study is not currently recruiting Study Participants on ClinicalConnection.com. If you would like to find active studies please search for clinical trials.

Palo Alto, California 94303


To provide oral ganciclovir to patients who require maintenance for control of cytomegalovirus (CMV) retinitis, but who lack patent permanent central venous access for long-term administration of intravenous drugs.

Study summary:

Patients receive oral ganciclovir as maintenance. Patients enrolled at time of closure of enrollment will receive 2 months of study drug and undergo follow-up.


Inclusion Criteria Patients must have: - AIDS. - Stable CMV retinitis. - Treatment with IV ganciclovir or IV foscarnet for at least 18 of the past 21 days. - No permanent central IV catheter at present. - Had a permanent central IV catheter removed two or more times within the past 6 months due to catheter infection or thrombosis. - Consent of guardian if less than legal age of consent. Exclusion Criteria Co-existing Condition: Patients with the following symptoms or conditions are excluded: - Require continuation of concomitant medications precluded by this protocol. Concurrent Medication: Excluded: - Intravitreal anti-CMV treatment. - Any other concomitant medications precluded by the protocol. Patients with the following prior condition are excluded: History of hypersensitivity to acyclovir or ganciclovir.



Primary Contact:


Backup Contact:


Location Contact:

Palo Alto, California 94303
United States

There is no listed contact information for this specific location.

Site Status: N/A

Data Source: ClinicalTrials.gov

Date Processed: October 09, 2019

Modifications to this listing: Only selected fields are shown, please use the link below to view all information about this clinical trial.

Click to view Full Listing

This study is not currently recruiting Study Participants on ClinicalConnection.com. The form below is not enabled.